Effect of Infraclavicular and Interscalen Block on Oxygenitaon of the Forearm

NCT04748211 | Completed DMC

• 1 other identifier: 2017-116-06/12
• Study Type: interventional
• Target: 104
• Locations: 1 country
• Sites: 1

Brief Summary

to research the oxygenitaon effects of infraclavicular and interscalene blocks on the forearm.

Conditions

Upper Extremity Fracture

Outcome Measures

Primary Outcomes (1)

• oxygenation of the forearm

  to compare the oxygenation of the forearm by measuring perfusion index device

  during the procedure three times

Study Arms (2)

Infraclavicular Block

EXPERIMENTAL

Group I received USG and neurostimulator guided infraclavicular block, 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.

Procedure: Infraclavicular Block

Interscalen Block

EXPERIMENTAL

Group II received USG and neurostimulator guided interscalen block. 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.

Procedure: Interscalen Block

Interventions

Infraclavicular Block PROCEDURE

USI and neurostimulator guided infraclavicular block, 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.

Infraclavicular Block

Interscalen Block PROCEDURE

USI and neurostimulator guided interscalen block, 10 ml 2% lidocain and 10 ml 0.05% marcaine was administered for local anetshesia. After the block was administered MAP, HR, TAV, BAD, BAA, BF, PI and rSO 2 values were measured and recorded at the 10th, 20th, and 30th minutes.

Interscalen Block

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• aged between 18-65
• ASA Score I-III
• undergoing elective or emergency arm, elbow and forearm surgery

You may not qualify if:

• Patient's refusal for Brachial Plexus Blockage
• Patients who had any neurological disorders preventing the evaluation of the sensory block in the upper extremity,
• Infection in the area to be blocked with ICB or ISB,
• Non-cooperated patients
• Patients with coagulopathy,
• Morbidly obese patients
• Patients with diabetes mellitus
• Patients with hypertension
• Patients with peripheral artery disease
• Patients with allergy to the drugsto be used
• Patients who had trauma in the area scheduled for the block
• Paitens who had deterioration of anatomical integrity because of previous surgery
• Pregnant women
• Patients whose block failed

Sponsors & Collaborators

• Bulent Ecevit University: lead

Study Sites (1)

Zonguldak Bulent Ecevit University

Zonguldak, Turkey (Türkiye)

Location

Study Officials

• Eren Açıkgöz, M.D.

  Bulent Ecevit University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: associate professor

Model Details: The study will be a two-arm parallel assignment. One group will receive infraclavicular block and the other will receive interscalen block

Study Record Dates

• First Submitted: December 13, 2020
• First Posted: February 10, 2021
• Study Start: June 15, 2018
• Primary Completion: June 15, 2019
• Study Completion: June 15, 2019
• Last Updated: February 12, 2021

Record last verified: 2021-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)